Maxell Ltd
TSE:6810
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Maxell Ltd
TSE:6810
|
JP |
|
M
|
MapLight Therapeutics Inc
NASDAQ:MPLT
|
US |
|
Mirae Asset Securities Co Ltd
KRX:006800
|
KR |
|
R
|
Region Re Ltd
ASX:RGN
|
AU |
|
R
|
R&G PharmaStudies Co Ltd
SZSE:301333
|
CN |
|
Conmed Corp
NYSE:CNMD
|
US |
Wall St Price Targets
Price Targets Summary
Maxell Ltd
According to Wall Street analysts, the average 1-year price target for Maxell Ltd is 2 382.43 JPY with a low forecast of 1 818 JPY and a high forecast of 3 150 JPY.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is Maxell Ltd's stock price target?
Price Target
2 382.43
JPY
According to Wall Street analysts, the average 1-year price target for Maxell Ltd is 2 382.43 JPY with a low forecast of 1 818 JPY and a high forecast of 3 150 JPY.
What is the Revenue forecast for Maxell Ltd?
Projected CAGR
5%
Over the last 13 years, the compound annual growth rate for Revenue has been 1%. The projected CAGR for the next 4 years is 5%.
What is the Gross Profit forecast for Maxell Ltd?
Projected CAGR
7%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 2%. The projected CAGR for the next 3 years is 7%.
What is the Pre-Tax Income forecast for Maxell Ltd?
Projected CAGR
28%
Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 11%. The projected CAGR for the next 3 years is 28%.
What is the Net Income forecast for Maxell Ltd?
Projected CAGR
29%
Over the last 13 years, the compound annual growth rate for Net Income has been 6%. The projected CAGR for the next 3 years is 29%.
